1 / 8

Philip J. Barter, et al. Circulation 2011;124:555-562

Philip J. Barter, et al. Circulation 2011;124:555-562. Baseline Characteristics of Randomized Subjects With Diabetes Mellitus – Part I. Philip J. Barter, et al. Circulation 2011;124:555-562. Baseline Characteristics of Randomized Subjects With Diabetes Mellitus – Part II.

mort
Download Presentation

Philip J. Barter, et al. Circulation 2011;124:555-562

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Philip J. Barter, et al. Circulation 2011;124:555-562

  2. Baseline Characteristics of Randomized Subjects With Diabetes Mellitus – Part I Philip J. Barter, et al. Circulation 2011;124:555-562

  3. Baseline Characteristics of Randomized Subjects With Diabetes Mellitus – Part II Philip J. Barter, et al. Circulation 2011;124:555-562

  4. Effects of Treatment With Atorvastatin vs the Combination of Atorvastatin and Torcetrapib on Plasma Glucose, Hemoglobin A1c, Serum Insulin,HOMA-IR, and HDL Cholesterol for the Subgroup of Diabetic Subjects Philip J. Barter, et al. Circulation 2011;124:555-562

  5. Between-Treatment Comparison of Changes in Glucose, Insulin, Hemoglobin A1c, and HOMA-IR Adjusted for Change in HDL Cholesterol - I Philip J. Barter, et al. Circulation 2011;124:555-562

  6. Between-Treatment Comparison of Changes in Glucose, Insulin, Hemoglobin A1c, and HOMA-IR Adjusted for Change in HDL Cholesterol - II Philip J. Barter, et al. Circulation 2011;124:555-562

  7. Effects of Treatment With Atorvastatin vs the Combination of Atorvastatin and Torcetrapib on Plasma Glucose, Hemoglobin A1c, Serum Insulin, HOMA-IR, and HDL Cholesterol for the Subgroup of Nondiabetic Subjects Philip J. Barter, et al. Circulation 2011;124:555-562

  8. CLINICAL PERSPECTIVE Philip J. Barter, et al. Circulation 2011;124:555-562

More Related